FDA-Drug2018-05-09Class II
Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
Sanofi-Aventis U.S. LLC
Hazard
Superpotent drug: over-concentrated vials of Docetaxel injection concentrate 20 mg/mL may have been distributed.
Sold states
US nationwide
Affected count
19580 vials
Manufactured in
55 Corporate Dr, N/A, Bridgewater, NJ, United States
Products
Docetaxel injection concentrate, 20 mg/mL, 1 mL vial, Rx only, Winthrop U.S. a business of Sanofi-Aventis U.S. LLC., NDC 0955-1020-01
Official notice
https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-0804-2018Don't want to check this manually?
We email you a Sunday digest of new federal recalls relevant to parents — free, no credit card. Or upgrade to as-it-happens alerts for the brands you actually own.
Get the Sunday Brief